Background: Patients with diabetes mellitus need information about the effectiveness of
innovations in insulin delivery and glucose monitoring. Purpose: To review how intensive …

Aims We compared the effects of continuous subcutaneous insulin infusion (CSII) with those
of multiple daily insulin (MDI) injections on glycaemic control, risk of hypoglycaemic …

ABSTRACT The American Association of Clinical Endocrinologists/American College of
Endocrinology Medical Guidelines for Clinical Practice are systematically developed …

Objective: To formulate clinical practice guidelines for the use of continuous glucose
monitoring and continuous subcutaneous insulin infusion in adults with diabetes …

Background Many patients with advanced type 2 diabetes do not meet their glycated
haemoglobin targets and randomised controlled studies comparing the efficacy of pump …

Insulin pumps have come of age. With their proliferation in medical practice, some guidance
is necessary for prospective and current prescribers to ensure their optimal and safe use …

Anumber of landmark randomized clinical trials established that insulin therapy reduces
microvascular complications (1, 2). In addition, recent follow-up data from the UK …

Aims The goal of the study was to determine whether continuous subcutaneous insulin
infusion (CSII) differs from a multiple daily injection (MDI) regimen based on neutral …

OBJECTIVE—To compare the efficacy and safety of continuous subcutaneous insulin
infusion (CSII) and multiple daily injection (MDI) in older adults with insulin-treated type 2 …

Context: Hypoglycemia limits the efficacy of intensive insulin therapy. The extent to which
continuous insulin infusion (CSII) overcomes this limitation is unclear. Objective: The aim …